BPG is committed to discovery and dissemination of knowledge
Articles Published Processes Featured Articles Journals Submit a Manuscript
Cited by in CrossRef
For: Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World J Hepatol 2019; 11(1): 1-18 [PMID: 30705715 DOI: 10.4254/wjh.v11.i1.1]
URL: https://www.wjgnet.com/1007-9327/full/v11/i1/1.htm
(497) (433) (0) (0) (21) (2) (24850) (268)
Number Citing Articles
1
Hala S. El-Rebey, Asmaa G. Abdou, Mervat M. Sultan, Shymaa H. Ibrahim, Nanis S. Holah. The Profile and Role of Tumor-infiltrating Lymphocytes in Hepatocellular Carcinoma: An Immunohistochemical Study. Applied Immunohistochemistry & Molecular Morphology 2021; 29(3) doi: 10.1097/PAI.0000000000000865
2
L.E. Cisneros-Garza, M.S. González-Huezo, C. Moctezuma-Velázquez, L. Ladrón de Guevara-Cetina, M. Vilatobá, I. García-Juárez, R. Alvarado-Reyes, G.A. Álvarez-Treviño, S. Allende-Pérez, L. Bornstein-Quevedo, G. Calderillo-Ruiz, M.A. Carrillo-Martínez, M. Castillo-Barradas, E. Cerda-Reyes, J.A. Félix-Leyva, J.A. Gabutti-Thomas, J. Guerrero-Ixtlahuac, F. Higuera-de-la-Tijera, D. Huitzil-Meléndez, E. Kimura-Hayama, P.A. López-Hernández, R. Malé-Velázquez, N. Méndez-Sánchez, M.A. Morales-Ruiz, E. Ruíz-García, J.F. Sánchez-Ávila, L. Torrecillas-Torres. The second Mexican consensus on hepatocellular carcinoma. Part I: Epidemiology and diagnosis. Revista de Gastroenterología de México (English Edition) 2022; 87(2) doi: 10.1016/j.rgmxen.2021.10.009
3
Joanne McDonagh, Sara Bardell, Neil Rajoriya, Isobel Hayes, Tahir Shah. Managing ascites in patients with hepatocellular carcinoma: experiences from a quaternary liver centre. Gastrointestinal Nursing 2024; 22(Sup1) doi: 10.12968/gasn.2024.22.Sup1.S17
4
Omayma A.R. AboZaid, Mostafa A. Abdel-Maksoud, Ibrahim A. Saleh, Mohamed A. El-Tayeb, Sawsan M. EL-sonbaty, Faten E. Shoker, Maha A. Salem, Ayat M. Emad, Samson Mani, Arunagiri Kuha Deva Magendhra Rao, Mohamed A. Mamdouh, Mohamed H. Kotob, Mohammed Aufy, Ahmad S. Kodous. Targeting the NF-κB p65/Bcl-2 signaling pathway in hepatic cellular carcinoma using radiation assisted synthesis of zinc nanoparticles coated with naturally isolated gallic acid. Biomedicine & Pharmacotherapy 2024; 172 doi: 10.1016/j.biopha.2024.116274
5
Daniel Jesper, Daniel Klett, Barbara Schellhaas, Lukas Pfeifer, Moritz Leppkes, Maximilian Waldner, Markus F. Neurath, Deike Strobel. Ultrasound-Based Attenuation Imaging for the Non-Invasive Quantification of Liver Fat - A Pilot Study on Feasibility and Inter-Observer Variability. IEEE Journal of Translational Engineering in Health and Medicine 2020; 8 doi: 10.1109/JTEHM.2020.3001488
6
Maira Bacchiega, Stefania D’Agostino, Antonella Grigoletto, Elena Poli, Paolo Bonvini, Gianni Bisogno, Gianfranco Pasut, Michela Pozzobon. Glypican 3 as target therapy to prevent cell migration and proliferation in rhabdomyosarcoma. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-03466-x
7
Suzan Abdu, Nouf Juaid, Amr Amin, Mohamed Moulay, Nabil Miled. Therapeutic Effects of Crocin Alone or in Combination with Sorafenib against Hepatocellular Carcinoma: In Vivo & In Vitro Insights. Antioxidants 2022; 11(9) doi: 10.3390/antiox11091645
8
Clara T. Nicolas, Caitlin J. VanLith, Raymond D. Hickey, Zeji Du, Lori G. Hillin, Rebekah M. Guthman, William J. Cao, Benjamin Haugo, Annika Lillegard, Diya Roy, Aditya Bhagwate, Daniel O’Brien, Jean-Pierre Kocher, Robert A. Kaiser, Stephen J. Russell, Joseph B. Lillegard. In vivo lentiviral vector gene therapy to cure hereditary tyrosinemia type 1 and prevent development of precancerous and cancerous lesions. Nature Communications 2022; 13(1) doi: 10.1038/s41467-022-32576-7
9
Mario Capasso, Valentina Cossiga, Maria Guarino, Luisa Ranieri, Filomena Morisco. The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis. Cancers 2024; 16(8) doi: 10.3390/cancers16081505
10
Yi Dong, Wen-Ping Wang, Won Jae Lee, Maria Franca Meloni, Dirk-Andre Clevert, Maria Cristina Chammas, Andrea Tannapfel, Antonella Forgione, Fabio Piscaglia, Christoph Frank Dietrich. Hepatocellular carcinoma in the non-cirrhotic liver. Clinical Hemorheology and Microcirculation 2022; 80(4) doi: 10.3233/CH-211309
11
Aishwarya Gaur, Shyam Sunder, Prabhat Narain Sharma. Nonislet Cell Tumor Hypoglycemia: A Rare Paraneoplastic Syndrome. Journal of The Association of Physicians of India 2025; 73(2) doi: 10.59556/japi.73.0837
12
Jieun Kim, Ekihiro Seki. Inflammation and Immunity in Liver Neoplasms: Implications for Future Therapeutic Strategies. Molecular Cancer Therapeutics 2025; 24(2) doi: 10.1158/1535-7163.MCT-23-0726
13
Yilin Pang, Yuanshan Lin, Xueqing Wang, Jing Wang, Qian Liu, Nan Ding, Lin Huang, Qiyu Xiang, Jun Fang, Guoqiang Tan, Jianxin Lyu, Zheng Wang. Inhibition of abnormally activated HIF-1α-GLUT1/3-glycolysis pathway enhances the sensitivity of hepatocellular carcinoma to 5-caffeoylquinic acid and its derivatives. European Journal of Pharmacology 2022; 920 doi: 10.1016/j.ejphar.2022.174844
14
K. P. Divya, Parneet Hari, Navjot Kanwar, Navita Aggarwal, Preeti Singh Dhoat, Lu Liu, Abhinav Kanwal, Shailendra Pratap Singh, Jiong Yu. The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics. Advanced Gut & Microbiome Research 2023; 2023 doi: 10.1155/2023/5431615
15
Yakup Ülger, Anıl Delik. AN UNUSUAL CASE OF RECURRENT GASTROINTESTINAL BLEEDING AND ACUTE RENAL FAILURE-RELATED HEPATOCELLULAR CARCINOMA WITH GASTRIC OUTLET OBSTRUCTION. Gastroenterology Nursing 2022; 45(5) doi: 10.1097/SGA.0000000000000694
16
Ellery Altshuler, Raymond Richhart, Mahmoud Aryan, William King, Kelsey Pan, Akash Mathavan, Akshay Mathavan, Diana Rodriguez, Bishal Paudel, Nathan Northern, Brian Ramnaraign, Ilyas Sahin, Jesus C Fabregas. Advanced Hepatocellular Carcinoma in Adults Without Cirrhosis: A Single-Institution Retrospective Review. Journal of Hepatocellular Carcinoma 2022;  doi: 10.2147/JHC.S384438
17
Alessia Virzì, Victor Gonzalez-Motos, Simona Tripon, Thomas F. Baumert, Joachim Lupberger. Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development. Journal of Clinical Medicine 2021; 10(5) doi: 10.3390/jcm10050977
18
K Reesha, Shameena Pazhaningal Mohamed, Sujatha Varma, Resmi G. Nair. Metastatic hepatocellular carcinoma of the oral cavity - A report of two cases. Journal of Oral and Maxillofacial Pathology 2023; 27(3) doi: 10.4103/jomfp.jomfp_515_22
19
Yucel Aydin, Ramazan Kurt, Kyoungsub Song, Dong Lin, Hanadi Osman, Brady Youngquist, John W. Scott, Nathan J. Shores, Paul Thevenot, Ari Cohen, Srikanta Dash. Hepatic Stress Response in HCV Infection Promotes STAT3-Mediated Inhibition of HNF4A-miR-122 Feedback Loop in Liver Fibrosis and Cancer Progression. Cancers 2019; 11(10) doi: 10.3390/cancers11101407
20
Kathleen MÖLLER, Mikael SAWATZKI, Christian JENSSEN, Carla SERRA, Sofia BAKKEN, Christian GÖRG, Yi DONG, Christoph F. DIETRICH. Pitfalls in contrast enhanced ultrasound: lack of washout in malignant liver lesions. A scoping review. Minerva Medica 2025; 116(5) doi: 10.23736/S0026-4806.25.09658-2
21
Jack Leslie, Daniel Geh, Ahmed M. Elsharkawy, Derek A. Mann, Michele Vacca. Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions. Journal of Hepatology 2022; 77(1) doi: 10.1016/j.jhep.2022.01.029
22
Markus Casper, Maximilian Linxweiler, Johannes Linxweiler, Richard Zimmermann, Matthias Glanemann, Frank Lammert, Susanne N. Weber. <b><i>SEC62</i></b> and <b><i>SEC63</i></b> Expression in Hepatocellular Carcinoma and Tumor-Surrounding Liver Tissue. Visceral Medicine 2021; 37(2) doi: 10.1159/000513293
23
Khaled Mahmoud, Shady Swidan, Mohamed El-Nabarawi, Mahmoud Teaima. Lipid based nanoparticles as a novel treatment modality for hepatocellular carcinoma: a comprehensive review on targeting and recent advances. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01309-9
24
Hongxin Cai, Xiaoyue Du, Yufeng Deng, Dejian Cao, Lele Wang, Zhiguo Wu, Xianchao Zhang, Jinbiao Xu, Baogang Xie. Pharmacokinetics and apparent Michaelis constant for metabolite conversion of sorafenib in healthy and hepatocellular carcinoma-bearing rats. Bioanalysis 2024; 16(10) doi: 10.4155/bio-2023-0215
25
Gianvito Candita, Sara Rossi, Karolina Cwiklinska, Salvatore Claudio Fanni, Dania Cioni, Riccardo Lencioni, Emanuele Neri. Imaging Diagnosis of Hepatocellular Carcinoma: A State-of-the-Art Review. Diagnostics 2023; 13(4) doi: 10.3390/diagnostics13040625
26
Juey-Ming Shih. Tumor Lysis Syndrome Following Thoracotomy Under Cardiopulmonary Bypass in a Case of Hepatocellular Carcinoma With Right Atrial and Inferior Vena Cava Tumor Thrombus. Cureus 2021;  doi: 10.7759/cureus.20311
27
Dafeng Xu, Yu Wang, Jincai Wu, Yuliang Zhang, Zhehao Liu, Yonghai Chen, Jinfang Zheng. Systematic Characterization of Novel Immune Gene Signatures Predicts Prognostic Factors in Hepatocellular Carcinoma. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.686664
28
Pakanat Decharatanachart, Kittiyod Poovorawan, Pisit Tangkijvanich, Phunchai Charatcharoenwitthaya, Thoetchai Peeraphatdit, Suthira Taychakhoonavudh, Sombat Treeprasertsuk, Roongruedee Chaiteerakij. Cost-Utility Analysis of Noninvasive Tests to Initiate Hepatocellular Carcinoma Surveillance in Metabolic Dysfunction-Associated Steatotic Liver Disease. American Journal of Gastroenterology 2025; 120(11) doi: 10.14309/ajg.0000000000003332
29
. 2019;  doi: 10.70675/f23f0221zd53ez41a4za07cz79c8f84bf6de
30
Mahnaz Mohammadi, Adeleh Attar, Maryam Mohammadbeigi, Amir Peymani, Shahin Bolori, Fatemeh Fardsanei. The possible role of Helicobacter pylori in liver diseases. Archives of Microbiology 2023; 205(8) doi: 10.1007/s00203-023-03602-z
31
Mauro Cataldi, Federica Manco, Giovanni Tarantino. Steatosis, Steatohepatitis and Cancer Immunotherapy: An Intricate Story. International Journal of Molecular Sciences 2021; 22(23) doi: 10.3390/ijms222312947
32
Mélanie Simoes Eugénio, Muhammad Farooq, Sarah Dion, Christelle Devisme, Céline Raguenes-Nicol, Claire Piquet-Pellorce, Michel Samson, Marie-Thérèse Dimanche-Boitrel, Jacques Le Seyec. Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response. Cancers 2020; 12(6) doi: 10.3390/cancers12061491
33
Yi Dong, Sheng Chen, Kathleen Möller, Yi-Jie Qiu, Xiu-Yun Lu, Qi Zhang, Christoph F. Dietrich, Wen-Ping Wang. Applications of Dynamic Contrast-Enhanced Ultrasound in Differential Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma in Non-cirrhotic Liver. Ultrasound in Medicine & Biology 2023; 49(8) doi: 10.1016/j.ultrasmedbio.2023.03.026
34
Dobrochna Dolicka, Cyril Sobolewski, Marta Correia de Sousa, Monika Gjorgjieva, Michelangelo Foti. mRNA Post-Transcriptional Regulation by AU-Rich Element-Binding Proteins in Liver Inflammation and Cancer. International Journal of Molecular Sciences 2020; 21(18) doi: 10.3390/ijms21186648
35
Hao-Yu Mao, Jing-Cheng Hu, Tao Zhang, Yan-Fen Fan, Xi-Ming Wang, Chun-Hong Hu, Yi-Xing Yu. Hepatocellular carcinoma (HCC) and focal nodular hyperplasia (FNH) showing iso- or hyperintensity in the hepatobiliary phase: differentiation using Gd-EOB-DTPA enhanced MRI radiomics and deep learning features. BMC Medical Imaging 2025; 25(1) doi: 10.1186/s12880-025-01927-3
36
Raksha K. R. Shastry, Adithya Kale, Sui Seng Tee. Cirrhosis severity modulates proteomic and immune landscapes in hepatocellular carcinoma. npj Gut and Liver 2026; 3(1) doi: 10.1038/s44355-026-00079-7
37
Noureen Kanwal, Jahanzaib Haider, Siraj Haider, Mohammad Iqbal, Kiran Amir, Faisal Saud Dar. EX vivo liver resection and auto transplantation for a giant hepatocellular carcinoma: A case report. International Journal of Surgery Case Reports 2024; 125(C) doi: 10.1016/j.ijscr.2024.110573
38
Amreen Dinani, Norman Sussman, Mazen Noureddin, Michael Fuchs, George Therapondos, Nigel Girgrah, Viviana Figueroa Diaz, Parvez Mantry, Mary Rinella, Amon Asgharpour, Douglas Dieterich. An algorithm for the management of non-alcoholic fatty liver disease in primary care. Gastroenterology & Hepatology: Open Access 2021; 12(4) doi: 10.15406/ghoa.2021.12.00469
39
Maryam Bilal Haider, Ali Al Sbihi, Ahmed Jamal Chaudhary, Syed M Haider, Ahmed Iqbal Edhi. Hereditary hemochromatosis: Temporal trends, sociodemographic characteristics, and independent risk factor of hepatocellular cancer – nationwide population-based study. World Journal of Hepatology 2022; 14(9): 1804-1816 doi: 10.4254/wjh.v14.i9.1804
40
Qiaoling Wang, Binxia Chang, Xiaoyan Li, Zhengsheng Zou. Role of ALDH2 in Hepatic Disorders: Gene Polymorphism and Disease Pathogenesis. Journal of Clinical and Translational Hepatology 2021; 0(000) doi: 10.14218/JCTH.2020.00104
41
Hiroko Naganuma, Hideaki Ishida. Hepatocellular Carcinoma in Non-Fibrotic Liver: A Narrative Review. Diagnostics 2023; 13(22) doi: 10.3390/diagnostics13223426
42
Raja Chhabra, Aditya Vidushi, Sajjan Rajpurohit, Jasbir Singh, Md Ali Osama. Spontaneous Tumor Lysis Syndrome in a Case of Hepatocellular Carcinoma with Sarcomatoid Differentiation. Indian Journal of Surgical Oncology 2024; 15(2) doi: 10.1007/s13193-024-01895-0
43
Mattias Lissing, Bruce Wang, Staffan Wahlin. Liver transplantation and primary liver cancer in porphyria. Liver International 2025; 45(3) doi: 10.1111/liv.15894
44
Hiroki Bessho, Satoshi Tanaka, Akio Ishihara, Shinya Kato, Reishi Toshiyama, Naoki Hama, Kiyoshi Mori, Masayuki Mano, Atsushi Miyamoto, Hisashi Ishida, Motohiro Hirao, Eiji Mita. Hepatocellular carcinoma in an adult patient with congenital absence of the portal vein type II: A case report. JGH Open 2020; 4(4) doi: 10.1002/jgh3.12312
45
Khaled Mahmoud, Mahmoud Teaima, Yasmeen Attia, Jingjing Sun, Mohamed El-Nabarawi, Shady Swidan. Reprogramming hepatocellular carcinoma: Nanomedicine at the crossroads of molecular targets and smart delivery. Colloids and Surfaces B: Biointerfaces 2026; 268 doi: 10.1016/j.colsurfb.2026.115981
46
Benedetta Maria Motta, Mario Masarone, Pietro Torre, Marcello Persico. From Non-Alcoholic Steatohepatitis (NASH) to Hepatocellular Carcinoma (HCC): Epidemiology, Incidence, Predictions, Risk Factors, and Prevention. Cancers 2023; 15(22) doi: 10.3390/cancers15225458
47
Maria Cristina Cuartas-Mesa, Maria E Romero Noboa, Yasmine Choroomi, Badri Aryal, Akash Venkataramanan, Rafaella Ferreira de Araujo Litvin. A Chronic Cough and Something More: An Unusual Presentation of Hepatocellular Carcinoma. Cureus 2023;  doi: 10.7759/cureus.37300
48
Ling Wu, Guanglei Tang, Shaodong Lu, Shulin Ma, Rulin Xu, IengHou Lam, Xiaowen Deng, Danfeng Zheng, Chang Li, Jian Guan. Pictorial review of abdominopelvic diseases with elevated alpha-fetoprotein levels. Abdominal Radiology 2026;  doi: 10.1007/s00261-026-05698-5
49
Sehwa Kim, Yoonseok Lee, Soo Min Bang, Haein Bak, Sun Young Yim, Young Sun Lee, Yang Jae Yoo, Young Kul Jung, Ji Hoon Kim, Yeon Seok Seo, Hyung Joon Yim, Soon Ho Um, Kwan Soo Byun, Jong Eun Yeon. Early Normalization of Alanine Aminotransferase during Antiviral Therapy Reduces Risk of Hepatocellular Carcinoma in HBV Patients. Journal of Clinical Medicine 2021; 10(9) doi: 10.3390/jcm10091840
50
Sebastian Deschler, Junika Pohl-Topcu, Lukas Ramsauer, Philippa Meiser, Sophia Erlacher, Robin P. Schenk, H. Carlo Maurer, Peng Shen, Juliane Kager, Joseph Zink, Karyna Pistrenko, Enric Redondo Monte, Julius Weber, Lena Wasmaier, Melanie Laschinger, Norbert Hüser, Fabian Geisler, Douglas Thorburn, Hanno Nieß, Gabriela M. Wiedemann, Hans Zischka, Mathias Heikenwälder, Karin Kleigrewe, Carolin Mogler, Jan P. Böttcher, Percy A. Knolle, Roland M. Schmid, Katrin Böttcher. Polyunsaturated fatty acid-induced metabolic exhaustion and ferroptosis impair the anti-tumour function of MAIT cells in MASLD. Journal of Hepatology 2025; 83(6) doi: 10.1016/j.jhep.2025.06.006
51
Juan Pang, Ke Chen, Shen Chen, Xu Chen. Global burden of nonalcoholic steatohepatitis-related liver cancer, 1990–2019: a systematic analysis for the GBD 2019. Diabetology & Metabolic Syndrome 2022; 14(1) doi: 10.1186/s13098-022-00885-y
52
Amira M. Elmoslemany, Mohamed Elzallat, Mai Hussein Abd-Elfatah, Dina Mostafa Mohammed, Eman E.Abd Elhady. Possible therapeutic effect of frankincense (Gum olibanum) and myrrh (Commiphora myrrha) resins extracts on DEN/CCL4 induced hepatocellular carcinoma in rats. Phytomedicine Plus 2024; 4(1) doi: 10.1016/j.phyplu.2023.100517
53
Dandan Huang, Dafen Xu, Wenxin Chen, Ruimei Wu, Yujuan Wen, Ailin Liu, Liqing Lin, Xinhua Lin, Xuewen Wang. Fe-MnO2 nanosheets loading dihydroartemisinin for ferroptosis and immunotherapy. Biomedicine & Pharmacotherapy 2023; 161 doi: 10.1016/j.biopha.2023.114431
54
Hafiza Arooba Riaz, Dur E. Nishwa, Ameer Fatima, Braira Wahid, Akhtar Ali, Babita Kumari, Muhammad Idrees. Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis. Heliyon 2023; 9(5) doi: 10.1016/j.heliyon.2023.e16169
55
Diwakar Suresh, Akshatha N. Srinivas, Divya P. Kumar. Etiology of Hepatocellular Carcinoma: Special Focus on Fatty Liver Disease. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.601710
56
Robert Mahn, Farsaneh Sadeghlar, Alexandra Bartels, Taotao Zhou, Tobias Weismüller, Patrick Kupczyk, Carsten Meyer, Florian C. Gaertner, Marieta Toma, Tim Vilz, Petra Knipper, Tim Glowka, Steffen Manekeller, Jörg Kalff, Christian P. Strassburg, Maria A. Gonzalez-Carmona. Multimodal and systemic therapy with cabozantinib for treatment of recurrent hepatocellular carcinoma after liver transplantation. Medicine 2021; 100(38) doi: 10.1097/MD.0000000000027082
57
Jacob George, Nicole L Allard, Stuart K Roberts, Leon A Adams, Jane Davies, Behzad Hajarizadeh, Jennifer H MacLachlan, Suzanne E Mahady, Rosalie Altus, Catherine Brown, David C Fry, Belinda Greenwood‐Smith, Natali Smud, Patricia C Valery, Nafisa Yussf, Kate Broun, Denise Campbell, Karen Canfell, Chelsea Carle Harrison, Victoria Freeman, Paul Grogan, Catherine Holliday, Suzanne Hughes, Anna Kelly, Cathelijne van Kemenade, Claire Latumahina, Amanda McAtamney, Megan Varlow, Joachim Worthington, Susan Yuill, Eleonora Feletto. Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendations. Medical Journal of Australia 2025; 223(8) doi: 10.5694/mja2.70061
58
Shu-Yein Ho, Po-Hong Liu, Chia-Yang Hsu, Yi-Hsiang Huang, Jia-I Liao, Chien-Wei Su, Ming-Chih Hou, Teh-Ia Huo. Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Cancers 2023; 15(7) doi: 10.3390/cancers15071925
59
Cedric Brackenier, Lisa Kinget, Sarah Cappuyns, Chris Verslype, Benoit Beuselinck, Jeroen Dekervel. Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma. Cancers 2023; 15(2) doi: 10.3390/cancers15020348
60
Vassilis G. Giannakoulis, Peter Dubovan, Eleni Papoutsi, Agapi Kataki, John Koskinas. Senescence in HBV-, HCV- and NAFLD- Mediated Hepatocellular Carcinoma and Senotherapeutics: Current Evidence and Future Perspective. Cancers 2021; 13(18) doi: 10.3390/cancers13184732
61
Yakup Ülger, Anil Delik. Paraneoplastic syndrome frequency and prognostic effect in hepatocellular carcinoma patients. European Journal of Gastroenterology & Hepatology 2022; 34(7) doi: 10.1097/MEG.0000000000002341
62
Mohamed Moussa, Dave Sprengers, Vera Ketting, Christian Ramakers, Robert A. de Man, Roy S. Dwarkasing, Harry L.A. Janssen, Antonius E. van Herwaarden, Eric.T.T.L. Tjwa, Milan J. Sonneveld. Clinical Utility and Diagnostic Accuracy of the GAAD Score in Non-Cirrhotic Patients With Focal Liver Lesions. Clinical Gastroenterology and Hepatology 2026; 24(10) doi: 10.1016/j.cgh.2026.01.042
63
Jennie J. Cao, Andy Shon, Luke Yoon, Aya Kamaya, Justin R. Tse. Diagnostic performance of CT/MRI LI-RADS v2018 in non-cirrhotic hepatitis C virus infection. Abdominal Radiology 2024; 50(4) doi: 10.1007/s00261-024-04589-x
64
Liuliu Cheng, Shichuan Hu, Jinhu Ma, Yongheng Shu, Yanwei Chen, Bin Zhang, Zhongbing Qi, Yunmeng Wang, Yan Zhang, Yuwei Zhang, Ping Cheng. Long noncoding RNA RP11-241J12.3 targeting pyruvate carboxylase promotes hepatocellular carcinoma aggressiveness by disrupting pyruvate metabolism and the DNA mismatch repair system. Molecular Biomedicine 2022; 3(1) doi: 10.1186/s43556-021-00065-w
65
M. Decraecker, J.-F. Blanc. Carcinome hépatocellulaire. EMC - Traité de médecine AKOS 2025; 28(4) doi: 10.1016/S1634-6939(25)49527-1
66
Antonia Reyes, Gerardo Ortiz, Luisa F. Duarte, Christian Fernández, Rosario Hernández-Armengol, Pablo A. Palacios, Yolanda Prado, Catalina A. Andrade, Linmar Rodriguez-Guilarte, Alexis M. Kalergis, Felipe Simon, Leandro J. Carreño, Claudia A. Riedel, Mónica Cáceres, Pablo A. González. Contribution of viral and bacterial infections to senescence and immunosenescence. Frontiers in Cellular and Infection Microbiology 2023; 13 doi: 10.3389/fcimb.2023.1229098
67
Chao Ma, Longkun Fan, Jingxian Wang, Lixia Hao, Jinqiu He. Hippo/Mst1 overexpression induces mitochondrial death in head and neck squamous cell carcinoma via activating β-catenin/Drp1 pathway. Cell Stress and Chaperones 2019; 24(4) doi: 10.1007/s12192-019-01008-9
68
C. Nelson Hayes, Peiyi Zhang, Kazuaki Chayama. Hepatocellular Carcinoma. 2019;  doi: 10.15586/hepatocellularcarcinoma.2019.ch5
69
Puru Rattan, Carlos D. Minacapelli, Vinod Rustgi. The Microbiome and Hepatocellular Carcinoma. Liver Transplantation 2020; 26(10) doi: 10.1002/lt.25828
70
Nan Zhang, Hui Xu, A‐Hong Ren, Qian Zhang, Da‐Wei Yang, Te Ba, Zhen‐Chang Wang, Zheng‐Han Yang. Does Training in LI‐RADS Version 2018 Improve Readers' Agreement with the Expert Consensus and Inter‐reader Agreement in MRI Interpretation?. Journal of Magnetic Resonance Imaging 2021; 54(6) doi: 10.1002/jmri.27688
71
Yueyue Yang, Jiafei Lin, Susu Guo, Xiangfei Xue, Yikun Wang, Shiyu Qiu, Jiangtao Cui, Lifang Ma, Xiao Zhang, Jiayi Wang. RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01689-8
72
Mingyue Song, Yuhao Tao, Hanjun Zhang, Mingzhan Du, Lingchuan Guo, Chunhong Hu, Weiguo Zhang. Gd-EOB-DTPA-enhanced MR imaging features of hepatocellular carcinoma in non-cirrhotic liver. Magnetic Resonance Imaging 2024; 114 doi: 10.1016/j.mri.2024.110241
73
Meng-Fei Xian, Wen-Tong Lan, Zhe Zhang, Ming-De Li, Xin-Xin Lin, Yang Huang, Hui Huang, Li-Da Chen, Qing-Hua Huang, Wei Wang. Enhancing hepatocellular carcinoma diagnosis in non-high-risk patients: a customized ChatGPT model integrating contrast-enhanced ultrasound. La radiologia medica 2025; 130(7) doi: 10.1007/s11547-025-01994-0
74
Rupie Jamwal, Venkatram Krishnan, Dinesh Singh Kushwaha, Rajat Khurana. Hepatocellular carcinoma in non-cirrhotic versus cirrhotic liver: a clinico-radiological comparative analysis. Abdominal Radiology 2020; 45(8) doi: 10.1007/s00261-020-02561-z
75
Xiaobin Chi, Zhijian Chen, Yongbiao Chen, Hanyin Hong, Jianda Yu, Lizhi Lv. Upregulation of lncRNA PTOV1‐AS1 in hepatocellular carcinoma contributes to disease progression and sorafenib resistance through regulating miR‐505. Journal of Biochemical and Molecular Toxicology 2023; 37(10) doi: 10.1002/jbt.23437
76
Han Deng, Wenting Shang, Kun Wang, Kunxiong Guo, Yu Liu, Jie Tian, Chihua Fang. Targeted-detection and sequential-treatment of small hepatocellular carcinoma in the complex liver environment by GPC-3-targeted nanoparticles. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01378-w
77
Hamzeh Karimkhanloo, Samira Mohammadi-Yeganeh, Razie Hadavi, Ameneh Koochaki, Mahdi Paryan. Potential role of miR-214 in β-catenin gene expression within hepatocellular carcinoma. Molecular Biology Reports 2020; 47(10) doi: 10.1007/s11033-020-05798-5
78
Benjamin Buchard, Camille Teilhet, Natali Abeywickrama Samarakoon, Sylvie Massoulier, Juliette Joubert-Zakeyh, Corinne Blouin, Christelle Reynes, Robert Sabatier, Anne-Sophie Biesse-Martin, Marie-Paule Vasson, Armando Abergel, Aicha Demidem. Two Metabolomics Phenotypes of Human Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease According to Fibrosis Severity. Metabolites 2021; 11(1) doi: 10.3390/metabo11010054
79
Tripti Khare, Alexei J. Stuckel, Suneel Gupta, Karina Liu, Ghassan M. Hammoud, Jamal A. Ibdah, Sharad Khare. Association of TP53 with Defective Long Chain 3-Hydroxy acyl-CoA Dehydrogenase Induced Non-Cirrhotic Hepatocellular Carcinoma. Cancers 2025; 17(19) doi: 10.3390/cancers17193241
80
Lu Yang, Claire Marie Shrestha, Andrii Kovalenko, Brian K.P. Goh, Alexander Y.F. Chung, Jin Yao Teo, London Lucien P.J. Ooi, Peng Chung Cheow, Prema Raj Jeyaraj, Ye Xin Koh, Fiona N.N. Moe, Jacelyn S.S. Chua, Ashley W.Y. Ng, Jade S.Q. Goh, Evelyn Y.L. Chiew, Cheryl M.E. Chua, Pierce K.H. Chow. Hepatocellular carcinoma of viral and non-viral etiologies has similar survival outcomes following curative intent surgical resection: a retrospective cohort study. International Journal of Surgery 2026;  doi: 10.1097/JS9.0000000000005343
81
Jianfei Sun, Huiying Yu, Bita Badehnoosh. Engineering chitosan nanoparticles for targeted doxorubicin delivery in liver cancer: A mechanistic and preclinical review. Carbohydrate Polymer Technologies and Applications 2025; 11 doi: 10.1016/j.carpta.2025.100992
82
Zongren Ding, Kongying Lin, Jun Fu, Qizhen Huang, Guoxu Fang, Yanyan Tang, Wuyi You, Zhaowang Lin, Zhan Lin, Xingxi Pan, Yongyi Zeng. An MR-based radiomics model for differentiation between hepatocellular carcinoma and focal nodular hyperplasia in non-cirrhotic liver. World Journal of Surgical Oncology 2021; 19(1) doi: 10.1186/s12957-021-02266-7
83
Afsaneh Barzi, Kali Zhou, Songren Wang, Jennifer L. Dodge, Anthony El-Khoueiry, Veronica Wendy Setiawan. Etiology and Outcomes of Hepatocellular Carcinoma in an Ethnically Diverse Population: The Multiethnic Cohort. Cancers 2021; 13(14) doi: 10.3390/cancers13143476
84
Jennie Engstrand, Per Stål, Stefan Gilg, Anders Jansson, Cecilia Strömberg. Hepatocellular carcinoma in cirrhotic versus non-cirrhotic liver: Treatment and survival differences in a nationwide cohort. Scandinavian Journal of Surgery 2024; 113(2) doi: 10.1177/14574969231220179
85
Suprabhat Giri, Sushrut Ingawale, Gaurav Khatana, Prasanna Gore, Dibya Lochan Praharaj, Vincent Wai‐Sun Wong, Daniel Q. Huang, Amit Singhal, Ashok Choudhury. Metabolic Cause of Cirrhosis Is the Emerging Etiology for Primary Liver Cancer in the Asia‐Oceania Region: Analysis of Global Burden of Disease (GBD) Study 2021. Journal of Gastroenterology and Hepatology 2025; 40(5) doi: 10.1111/jgh.16922
86
Manisri Porukala, P. K. Vinod, Amy McCart Reed. Gene expression signatures of stepwise progression of Hepatocellular Carcinoma. PLOS ONE 2023; 18(12) doi: 10.1371/journal.pone.0296454
87
Stefano Mazza, Chiara Frigerio, Daniele Alfieri, Aurelio Mauro, Francesca Torello Viera, Davide Scalvini, Chiara Barteselli, Carmelo Sgarlata, Letizia Veronese, Marco Bardone, Laura Rovedatti, Simona Agazzi, Elena Strada, Lodovica Pozzi, Marcello Maestri, Valentina Ravetta, Andrea Anderloni. Prognostic Role of Basal Serum Alpha-Fetoprotein in Patients with Hepatocellular Carcinoma Suitable for Curative Treatment. Medicina 2024; 60(5) doi: 10.3390/medicina60050692
88
Marie Decraecker, Heloise Bourien, Jean-Frédéric Blanc, Julien Edeline. Impact of Child Pugh B Stage for the Treatment of Advanced HCC. Journal of Hepatocellular Carcinoma 2026;  doi: 10.2147/JHC.S579537
89
Mariana Ferreira Cardoso, Mariana Verdelho Machado. The Changing Face of Hepatitis Delta Virus Associated Hepatocellular Carcinoma. Cancers 2024; 16(22) doi: 10.3390/cancers16223723
90
Giovanni Vitale, Alessandro Mattiaccio, Amalia Conti, Laura Turco, Marco Seri, Fabio Piscaglia, Maria Cristina Morelli. Genetics in Familial Intrahepatic Cholestasis: Clinical Patterns and Development of Liver and Biliary Cancers: A Review of the Literature. Cancers 2022; 14(14) doi: 10.3390/cancers14143421
91
Ayoob Dinar Abdullah, Behzad Amanpour-Gharaei, Mohssen Nassiri Toosi, Sina Delazar, Hamidraza Saligheh Rad, Arvin Arian. Comparing Texture Analysis of Apparent Diffusion Coefficient MRI in Hepatocellular Adenoma and Hepatocellular Carcinoma. Cureus 2024;  doi: 10.7759/cureus.51443
92
Ahmed M Badheeb, Mohammed K Al Sedran, Faisal Ahmed, Ibrahim K Al Sidran, Mohammed H Al Qurayshah, Abdullah Abu Bakar, Hamoud Y Obied, Islam A Seada, Abdelaziz Aman, Mohamed Badheeb. Clinical Characteristics and Survival of Hepatocellular Carcinoma: Insights from Single-Centre Experience in Saudi Arabia. Cureus 2024;  doi: 10.7759/cureus.52608
93
Qimeng Chang, Yayun Xu, Jianfa Wang, Hui Jing, Longhua Rao, Weiguo Tang, Ziping Zhang, Xubo Wu, Jianxin Shi. SLC41A3 Exhibits as a Carcinoma Biomarker and Promoter in Liver Hepatocellular Carcinoma. Computational and Mathematical Methods in Medicine 2021; 2021 doi: 10.1155/2021/8556888
94
Philip J. Johnson, Anton Kalyuzhnyy, Ellen Boswell, Hidenori Toyoda. Progression of chronic liver disease to hepatocellular carcinoma: implications for surveillance and management. BJC Reports 2024; 2(1) doi: 10.1038/s44276-024-00050-0
95
Dina Sweed, Enas Sweed, Inas Moaz, Asmaa Mosbeh, Yahya Fayed, Sara Mohamed Abd Elhamed, Eman Sweed, Mahmoud Macshut, Shimaa Abdelsattar, Shimaa Kilany, Sara A. Saied, Reda Badr, Mahmoud S. Abdallah, Nermine Ehsan. The clinicopathological and prognostic factors of hepatocellular carcinoma: a 10-year tertiary center experience in Egypt. World Journal of Surgical Oncology 2022; 20(1) doi: 10.1186/s12957-022-02764-2
96
Wasitha P.D. Wass Thilakarathna, H.P. Vasantha Rupasinghe, Neale D. Ridgway. Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2021; 22(5) doi: 10.3390/ijms22052606
97
Sarah El-Nakeep. Molecular and genetic markers in hepatocellular carcinoma: <i>In silico </i>analysis to clinical validation (current limitations and future promises). World Journal of Gastrointestinal Pathophysiology 2022; 13(1): 1-14 doi: 10.4291/wjgp.v13.i1.1
98
Francesco Siviero, Muhammad Ali Muslimani, Sonia Lerta, Sofia Frattola, Pietro Valsecchi, Raffaella Lissandrin, Laura Maiocchi, Marcello Maestri, Alessandro Vanoli, Angela Maria Di Matteo, Raffaele Bruno, Enrico Brunetti, Sreeja Dattachoudhury. The Abscess That Was Cancer: Pyogenic Liver Abscess as the Initial Manifestation of Hepatocellular Carcinoma in a Noncirrhotic Patient. Case Reports in Hepatology 2026; 2026(1) doi: 10.1155/crhe/9286315
99
Clara Bihain, Jean Delwaide, Paul Meunier, Laurent Gerard, Alexandre Jadoul, Olivier Detry. Successful multimodal management of a large hepatocellular carcinoma in a non-cirrhotic liver: a case report. Acta Chirurgica Belgica 2024; 124(3) doi: 10.1080/00015458.2023.2234724
100
Joscha Vonderlin, Triantafyllos Chavakis, Michael Sieweke, Frank Tacke. The Multifaceted Roles of Macrophages in NAFLD Pathogenesis. Cellular and Molecular Gastroenterology and Hepatology 2023; 15(6) doi: 10.1016/j.jcmgh.2023.03.002
101
Srikanta Dash, Yucel Aydin, Kyle E Widmer, Leela Nayak. <p>Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment</p>. Journal of Hepatocellular Carcinoma 2020;  doi: 10.2147/JHC.S221187
102
Santhosh Anand, Loganathan Jayapal, Siddhesh Suresh Tasgaonkar Ema, Jainudeen Khalander Abdul Jameel, Prasanna Kumar Reddy. Laparoscopic right posterior sectionectomy for a large hepatocellular carcinoma close to inferior vena cava. Journal of Minimally Invasive Surgery 2023; 26(3) doi: 10.7602/jmis.2023.26.3.162
103
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and Management. Endocrine Reviews 2020; 41(1) doi: 10.1210/endrev/bnz009
104
Hsin-Yeh Chen, Kwong-Ming Kee, Sheng-Nan Lu, Jing-Houng Wang, Chien-Hung Chen, Chao-Hung Hung, Yi-Hao Yen, Yuan-Hung Kuo. Incorporating albumin-bilirubin grade and up-to-seven criteria to predict outcomes of patients with intermediate stage hepatocellular carcinoma after transarterial (chemo)embolization. Journal of the Formosan Medical Association 2022; 121(4) doi: 10.1016/j.jfma.2021.07.003
105
Fatima Dahboul, Jihan Sun, Benjamin Buchard, Natali Abeywickrama‐Samarakoon, Estelle Pujos‐Guillot, Stéphanie Durand, Mélanie Petera, Delphine Centeno, Francesca Guerrieri, Massimiliano Cocca, Massimo Levrero, Adrien Rossary, Delphine Weil, Vincent Di Martino, Aicha Demidem, Armando Abergel. Simultaneous Activation of Beta‐Oxidation and De Novo Lipogenesis in MASLD‐HCC: A New Paradigm. Liver International 2025; 45(2) doi: 10.1111/liv.70006
106
Xuan-vinh Kevin Nguyen, Jason Zhang, Ken Lee Chin, Stephen Bloom, Amanda J. Nicoll. Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver?. Nutrients 2022; 14(18) doi: 10.3390/nu14183875
107
Georgi Atanasov, Karoline Dino, Katrin Schierle, Corinna Dietel, Gabriela Aust, Johann Pratschke, Daniel Seehofer, Moritz Schmelzle, Hans-Michael Hau. Immunologic cellular characteristics of the tumour microenvironment of hepatocellular carcinoma drive patient outcomes. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1635-3
108
Scott L. Friedman, Arun J. Sanyal. The future of hepatology. Hepatology 2023; 78(2) doi: 10.1097/HEP.0000000000000389
109
Sheng Chen, Yi-Jie Qiu, Dan Zuo, Shuai-Nan Shi, Wen-Ping Wang, Yi Dong. Imaging Features of Hepatocellular Carcinoma in the Non-Cirrhotic Liver with Sonazoid-Enhanced Contrast-Enhanced Ultrasound. Diagnostics 2022; 12(10) doi: 10.3390/diagnostics12102272
110
Arun Kumar Gunasekaran, Amit Malviya, Tony Ete, Animesh Mishra, Bhupen Barman, Md Jamil, Donboklang Lynser. Hepatocellular Carcinoma with Inferior Vena Cava and Right Atrium Tumor Thrombus. Acta medica Lituanica 2021; 28(2) doi: 10.15388/Amed.2021.28.2.10
111
Mindy X. Wang, M. Azfar Siddiqui, Alexandra Roudenko, Amita Kamath, Humaira Chaudhry, Roopa Ram, Amir A. Borhani, Venkateswar Surabhi, Khaled M. Elsayes, Robert M. Marks, Maxime Ronot. Magnetic resonance imaging of hepatocellular carcinoma: a spectrum of uncommon morphologic subtypes, unusual imaging patterns and mimics. Abdominal Radiology 2025; 50(7) doi: 10.1007/s00261-024-04773-z
112
Lampros Chrysavgis, Ilias Giannakodimos, Panagiota Diamantopoulou, Evangelos Cholongitas. Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link. World Journal of Gastroenterology 2022; 28(3): 310-331 doi: 10.3748/wjg.v28.i3.310
113
Eloy Ruiz, Jorge Honles, Ramiro Fernández, Karla Uribe, Juan P. Cerapio, Karina Cancino, Juan Contreras-Mancilla, Sandro Casavilca-Zambrano, Francisco Berrospi, Pascal Pineau, Stéphane Bertani. A preoperative risk score based on early recurrence for estimating outcomes after resection of hepatocellular carcinoma in the non-cirrhotic liver. HPB 2024; 26(5) doi: 10.1016/j.hpb.2024.02.010
114
Jing Yao, Zhe Yang, Jun Yang, Zhi-Gang Wang, Zheng-Yun Zhang. Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis. Aging 2021; 13(10) doi: 10.18632/aging.202960
115
Dipanjan Ghosh, Aharna Guin, Aryan Kumar, Amlan Das, Santanu Paul. Comprehensive insights of etiological drivers of hepatocellular carcinoma: Fostering targeted nano delivery to anti-cancer regimes. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2025; 1880(3) doi: 10.1016/j.bbcan.2025.189318
116
Sheridan L. Reed, Vishnu M. Chandra, William F. Pritchard, Andrew S. Mikhail, John W. Karanian, Carla S. Coffin, Bradford J. Wood, Luke R. Wilkins. The Woodchuck Hepatitis Virus Model of Hepatocellular Carcinoma for Interventional Radiology Research. Journal of Vascular and Interventional Radiology 2025; 36(12) doi: 10.1016/j.jvir.2025.09.002
117
Haeryoung Kim, Wei-Qiang Leow, Regina Lo, Paulo Giovanni L. Mendoza, Anthony Wing-Hung Chan. Atlas of Hepatocellular Carcinoma Pathology. 2022;  doi: 10.1007/978-981-16-8500-2_2
118
Daniel Q. Huang, Hashem B. El-Serag, Rohit Loomba. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nature Reviews Gastroenterology & Hepatology 2021; 18(4) doi: 10.1038/s41575-020-00381-6
119
Stefania Brozzetti, Chiara D’Alterio, Simone Bini, Jessica Antimi, Bianca Rocco, Alessia Fassari, Pierleone Lucatelli, Piergiorgio Nardis, Michele Di Martino, Giuseppe Maria De Sanctis, Mario Corona, Oreste Bagni, Enrico Cortesi, Mario Bezzi, Carlo Catalano. Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients—A Retrospective Observational Study. Cancers 2022; 14(18) doi: 10.3390/cancers14184422
120
Lampros Chrysavgis, Evangelos Cholongitas. Recent Advances in Liver Cirrhosis Related Complications. 2025;  doi: 10.1016/B978-0-443-21938-2.00020-5
121
Mikael Sawatzki, Daniela B. Husarik, David Semela. Assessment of focal liver lesions in non-cirrhotic liver – expert opinion statement by the Swiss Association for the Study of the Liver and the Swiss Society of Gastroenterology. Swiss Medical Weekly 2023; 153(9) doi: 10.57187/smw.2023.40099
122
Misako Nagasaka, Bayan Al-Share, Yusra F. Shao, Rachel Sexton, Mohammed Najeeb Al Hallak, Asfar S. Azmi, Ammar Sukari. Comprehensive Gut Microbiota. 2022;  doi: 10.1016/B978-0-12-819265-8.00047-4
123
Siyu Fu, José D. Debes, André Boonstra. DNA methylation markers in the detection of hepatocellular carcinoma. European Journal of Cancer 2023; 191 doi: 10.1016/j.ejca.2023.112960
124
Stefania Brozzetti, Marsia Tancredi, Simone Bini, Chiara De Lucia, Jessica Antimi, Chiara D’Alterio, Giuseppe Maria De Sanctis, Caterina Furlan, Vittoria Carolina Malpassuti, Pierleone Lucatelli, Michele Di Martino, Mario Bezzi, Antonio Ciardi, Rosa Maria Pascale. HCC in the Era of Direct-Acting Antiviral Agents (DAAs): Surgical and Other Curative or Palliative Strategies in the Elderly. Cancers 2021; 13(12) doi: 10.3390/cancers13123025
125
Fabio Sandomenico, Valerio Arpaia, Ferdinando De Rosa, Orlando Catalano, Roberto Antonino Buonaiuto, Marianna Notarangelo, Maria Iovino, Sabrina Giovine, Arturo Brunetti, Mariano Scaglione. Spontaneously Ruptured Hepatocellular Carcinoma: Computed Tomography-Based Assessment. Diagnostics 2023; 13(6) doi: 10.3390/diagnostics13061021
126
Mahmoud Aryan, Thomas Ruli, Mohamed Shoreibah. HCC in patients without cirrhosis: A review. Clinical Liver Disease 2024; 23(1) doi: 10.1097/CLD.0000000000000224
127
Ahdab S Bawashkhah, Ghufran A Sindi, Shahad B Almatrafi, Elaf F Obaid, Reda I Bakhsh. Fibrolamellar Hepatocellular Carcinoma in the Absence of Risk Factors: A Case Report. Cureus 2022;  doi: 10.7759/cureus.32483
128
Gitanjali Bajaj, Karthik Sundaram, Kedar Jambhekar, Roopa Ram. Imaging After Locoregional Therapy for Hepatocellular Carcinoma With Emphasis on LIRADS Treatment Response Assessment Criteria. Seminars in Ultrasound, CT and MRI 2021; 42(4) doi: 10.1053/j.sult.2021.03.002
129
Sayed Metwaly, Alicja Psica, Opeyemi Sogaolu, Irfan Ahmed, Ashis Mukhopadhya, Mirela Delibegović, Mohamed Bekheit. Volatile organic compounds for the detection of hepatocellular carcinoma—A scoping review. iLIVER 2024; 3(1) doi: 10.1016/j.iliver.2023.09.001
130
Samira Nafar, Jafar Fallahi, Sepideh Moradi, Gholamhossein Tamaddon, Seyed Mohammad Bagher Tabei. miR-153 Overexpression and BCL2 Targeting Induce Apoptosis and Autophagy in HepG2 Cells. Indian Journal of Clinical Biochemistry 2025;  doi: 10.1007/s12291-025-01343-y
131
Bisha Ding, Weiyang Lou, Jingxing Liu, Ruohan Li, Jing Chen, Weimin Fan. In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0901-3
132
Yuqi Feng, Letian Fang, Guangwen Cao. Epidemiological characteristics and precise prophylaxis and control of HBV-associated primary liver cancer. Hepatoma Research 2025;  doi: 10.20517/2394-5079.2024.132
133
Lamiaa Mahmoud Kamel, Nagwa Mohamed Shawky, Amal A Jouda, Amany Mohamed Ibrahim, Heba H. Mahboub, Sherif Y. Mohammed. Assessment of ghrelin serum level and gene polymorphism as a risk factor in progression of chronic viral hepatitis. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-99037-1
134
Monica Pibiri, Gabriella Simbula. Role of the Hippo pathway in liver regeneration and repair: recent advances. Inflammation and Regeneration 2022; 42(1) doi: 10.1186/s41232-022-00235-5
135
Yi-Te Lee, Benjamin V. Tran, Jasmine J. Wang, Icy Y. Liang, Sungyong You, Yazhen Zhu, Vatche G. Agopian, Hsian-Rong Tseng, Ju Dong Yang. The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma. Cancers 2021; 13(12) doi: 10.3390/cancers13123076
136
Coskun Ozer Demirtas, Maurizia Rossana Brunetto. Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?. World Journal of Gastroenterology 2021; 27(33): 5536-5554 doi: 10.3748/wjg.v27.i33.5536
137
Elizabeth SL Low, Ross Apostolov, Darren Wong, Sandra Lin, Numan Kutaiba, Josephine A Grace, Marie Sinclair. Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients. World Journal of Gastrointestinal Oncology 2021; 13(12): 2149-2160 doi: 10.4251/wjgo.v13.i12.2149
138
Valerie Ohlendorf, Yvonne Serfert, Peter Buggisch, Stefan Mauss, Hartwig Klinker, Gerlinde Teuber, Markus Cornberg, Krzysztof Tomasiewicz, Heiner Wedemeyer. Impact of distinct antiviral treatment regimens on the long-term outcome after HCV cure – Data from the German Hepatitis C-Registry (DHC-R). Zeitschrift für Gastroenterologie 2025; 63(05) doi: 10.1055/a-2543-5205
139
Max Kabolowsky, Lyndsey Nguyen, Brett E. Fortune, Ernesto Santos, Sirish Kishore, Juan C. Camacho. Interventional Management of Portal Hypertension in Cancer Patients. Current Oncology Reports 2022; 24(11) doi: 10.1007/s11912-022-01319-8
140
Tarig Abdelrahman, Mohamed Ali, Anika Ahmed, Harini Rangarajan. Intracardiac Mass Reveals Hepatocellular Carcinoma: A Rare Case of Cardiac Metastasis. Cureus 2025;  doi: 10.7759/cureus.97501
141
Georgi Atanasov, Karoline Dino, Katrin Schierle, Corinna Dietel, Gabriela Aust, Johann Pratschke, Daniel Seehofer, Moritz Schmelzle, Hans-Michael Hau. Angiogenic inflammation and formation of necrosis in the tumor microenvironment influence patient survival after radical surgery for de novo hepatocellular carcinoma in non-cirrhosis. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1756-8
142
Valentina Liakina, Sandra Strainiene, Ieva Stundiene, Vaidota Maksimaityte, Edita Kazenaite. Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis. World Journal of Hepatology 2022; 14(7): 1277-1290 doi: 10.4254/wjh.v14.i7.1277
143
McKenzie J. White, Eric H. Jensen, David G. Brauer. A Review of Resection and Surgical Ablation for Primary and Secondary Liver Cancers. Seminars in Interventional Radiology 2023; 40(06) doi: 10.1055/s-0043-1777747
144
A. Riojas-Garza, M. González-Urquijo, C.E. Escareño-Pérez, I. Vázquez-Ávila, F.J. Bosques-Padilla. Carcinoma hepatocelular de lóbulo caudado en un paciente no cirrótico con historia de administración de fenitoína crónica y enfermedad celíaca tratada con resección aislada de lóbulo caudado. Un reporte de caso. Revista de Gastroenterología de México 2022; 87(2) doi: 10.1016/j.rgmx.2022.03.001
145
M. Decraecker, J.-F. Blanc. Carcinoma hepatocelular. EMC - Tratado de Medicina 2026; 30(1) doi: 10.1016/S1636-5410(26)51350-3
146
Monika Péčová, Jakub Benko, Martin Jozef Péč, Jakub Jurica, Simona Horná, Tomáš Bolek, Tatiana Hurtová, Ján Sýkora, Kamil Zeleňák, Matej Samoš, Juraj Sokol. A Rare Early-Onset Fatal Complication after Transarterial Chemoembolization: A Case Report and Review of the Literature. Current Oncology 2024; 31(4) doi: 10.3390/curroncol31040147
147
Moris Sangineto, Rosanna Villani, Francesco Cavallone, Antonino Romano, Domenico Loizzi, Gaetano Serviddio. Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma. Cancers 2020; 12(6) doi: 10.3390/cancers12061419
148
Nur Fatin Najihah Marzuki, Yusmazura Zakaria. Medicinal Plants in the Regulation of PD-L1/PD-1 Immune Checkpoint of Various Human Cancer Cells: A Narrative Review. Current Cancer Therapy Reviews 2023; 19(2) doi: 10.2174/1573394718666220829125338
149
Paolo Gallo, Marianna Silletta, Federica Lo Prinzi, Tommaso Farolfi, Alessandro Coppola. Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: A Modern Context for an Ancient Disease. Journal of Clinical Medicine 2023; 12(14) doi: 10.3390/jcm12144605
150
. 2021;  doi: 10.70675/ad7bd189z46afz42a0za237z014930bed948
151
Rong Liu, Ming-Ping Qian, Ying-Yu Cui. Protein kinases: The key contributors in pathogenesis and treatment of nonalcoholic fatty liver disease-derived hepatocellular carcinoma. Metabolism 2023; 147 doi: 10.1016/j.metabol.2023.155665
152
Edgar Xchel Franco-Juárez, Vianey González-Villasana, María Elena Camacho-Moll, Luisa Rendón-Garlant, Patricia Nefertari Ramírez-Flores, Beatriz Silva-Ramírez, Katia Peñuelas-Urquides, Ethel Daniela Cabello-Ruiz, Fabiola Castorena-Torres, Mario Bermúdez de León. Mechanistic Insights about Sorafenib-, Valproic Acid- and Metformin-Induced Cell Death in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(3) doi: 10.3390/ijms25031760
153
Carly Lamb, Jennifer Tham, Tee Lin Goh, Stephen Barclay, Matthew Priest, Ewan H Forrest, Andrew Fraser, David Kay, Ram Kasthuri, Jeff Evans, Adrian J Stanley. Comparison between patient characteristics, aetiology and outcomes in patients with and without cirrhosis with hepatocellular carcinoma diagnosed in a regional centre. Frontline Gastroenterology 2024; 15(5) doi: 10.1136/flgastro-2024-102676
154
Song-Chen Dong, Dou-Sheng Bai, Fu-An Wang, Sheng-Jie Jin, Chi Zhang, Bao-Huan Zhou, Guo-Qing Jiang. Radiofrequency ablation is an inferior option to liver resection for solitary hepatocellular carcinoma ≤ 5 cm without cirrhosis: A population-based study with stratification by tumor size. Hepatobiliary & Pancreatic Diseases International 2023; 22(6) doi: 10.1016/j.hbpd.2022.08.001
155
Anna Michelotti, Marco de Scordilli, Lorenza Palmero, Michela Guardascione, Mario Masala, Rossana Roncato, Luisa Foltran, Elena Ongaro, Fabio Puglisi. NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome. Cells 2021; 10(8) doi: 10.3390/cells10082034
156
Aditya Kale. Hepatocellular Carcinoma - Challenges and Opportunities of a Multidisciplinary Approach. 2022;  doi: 10.5772/intechopen.99839
157
Emilio De Raffele. Liver Diseases. 2020;  doi: 10.1007/978-3-030-24432-3_31
158
Shohei Kurokawa, Toshiyuki Tanaka, Hiroki Yamazaki, Shunsuke Noguchi, Yusuke Wada, Hidetaka Nishida, Hideo Akiyoshi. Comparing the CT and MRI findings for canine primary hepatocellular lesions. Veterinary Record 2022; 190(11) doi: 10.1002/vetr.1083
159
Runmin Cao, Honghe Jiang, Guangpeng Liang, Weibin Zhang. SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(13) doi: 10.1007/s00432-023-05057-7
160
RESHMA T. MATE, ANURADHA N. CHIVATE, NAMDEO R. JADHAV, NIRANJAN D. CHIVATE. ADVANCING CURCUMIN APPLICATIONS IN HEPATOCELLULAR CARCINOMA: INSIGHTS INTO PHARMACOKINETICS, PHARMACODYNAMICS AND NANODELIVERY SYSTEMS. International Journal of Applied Pharmaceutics 2025;  doi: 10.22159/ijap.2025v17i4.53730
161
Kanokwan Pinyopornpanish, Wael Al-Yaman, Srinivasan Dasarathy, Carlos Romero-Marrero, Arthur McCullough. Hepatocellular Carcinoma in Patients Without Cirrhosis: The Fibrosis Stage Distribution, Characteristics and Survival. Digestive Diseases and Sciences 2022; 67(6) doi: 10.1007/s10620-021-07048-5
162
Bjarki Sigurdsson, Ragna Sigurdardottir, Margret B. Arnardottir, Sigrun H. Lund, Jon G. Jonasson, Einar S. Björnsson. A nationwide study on hepatocellular carcinoma. Cancer Epidemiology 2020; 69 doi: 10.1016/j.canep.2020.101835
163
Poonamjeet Loyal, Samuel Gitau, Soraiya Manji, Sitna Mwanzi, John Weru. Unusual presentation of hepatocellular carcinoma: Case report and review of literature. BJR|case reports 2021; 7(4) doi: 10.1259/bjrcr.20210033
164
Timothy M. Block, Ju-Tao Guo, Fabien Zoulim, Charles M. Rice, Chloe L. Thio, William M. Schneider, Harvey J. Alter, Ira M. Jacobson, Robert G. Gish, Peter D. Block, Mark Sulkowski, Jordan J. Feld, Chari A. Cohen. New potent HBV replication inhibitors for the management of chronic hepatitis B are needed. Nature Reviews Gastroenterology & Hepatology 2025; 22(3) doi: 10.1038/s41575-025-01037-z
165
Uffe Kjærgaard, Nikolaj Bøgh, Malene Aastrup, Mattias Hedegaard Kristensen, Nichlas Vous Christensen, Kim Sivesgaard, Steffen Ringgaard, Lotte Bonde Bertelsen, Esben Søvsø Szocska Hansen, Henning Grønbæk, Gerda Elisabeth Villadsen, Christoffer Laustsen. Proof-of-Concept Study of Hyperpolarized [1-13C]Pyruvate MRI in Participants with Hepatocellular Carcinoma. Radiology: Imaging Cancer 2026; 8(5) doi: 10.1148/rycan.250784
166
Sudhakar K. Venkatesh. Imaging in MASLD. Expert Review of Gastroenterology & Hepatology 2026; 20(3) doi: 10.1080/17474124.2026.2636184
167
Jihan Sun, Fatima Dahboul, Estelle Pujos-Guillot, Mélanie Petera, Emeline Chu-Van, Benoit Colsch, Delphine Weil, Vincent Di Martino, Aicha Demidem, Armando Abergel. PLD2 is a marker for MASLD-HCC with early-stage fibrosis: revealed by lipidomic and gene expression analysis. Metabolomics 2025; 21(2) doi: 10.1007/s11306-025-02226-2
168
Emma A. Schindler, Melissa A. Gilbert, David A. Piccoli, Nancy B. Spinner, Ian D. Krantz, Kathleen M. Loomes. Alagille syndrome and risk for hepatocellular carcinoma: Need for increased surveillance in adults with mild liver phenotypes. American Journal of Medical Genetics Part A 2021; 185(3) doi: 10.1002/ajmg.a.62028
169
Jacob Y. Cao, Kathyrn M. Wales, Yves d’Udekem, David S. Celermajer, Rachael Cordina, Avik Majumdar. Prevalence, Risk Factors, and Prognosis for Fontan-Associated Liver Disease. JACC: Advances 2025; 4(5) doi: 10.1016/j.jacadv.2025.101694
170
Barış Can Arslan, Banu Alıcıoğlu. Study of Ancillary and Novel Morphometric CT and MRI Biomarkers in Stage I-III Fibrosis in Chronic Liver Disease Patients. European Journal of Therapeutics 2026;  doi: 10.58600/eurjther3062
171
Matthew Thomas, Manjiri Dighe, Orpheus Kolokythas, Mladen Zecevic, Ann Wilson, Todd Erpelding, Theodore J. Dubinsky. Ultrasound Attenuation Imaging vs MRI-PDFF, Echogenicity and Liver Function for Assessing Degree of Steatosis in NAFLD and Non-NAFLD Patients. Ultrasound Quarterly 2023; 39(4) doi: 10.1097/RUQ.0000000000000648
172
Nicola Pugliese, Ludovico Alfarone, Ivan Arcari, Silvia Giugliano, Tommaso Lorenzo Parigi, Maria Rescigno, Ana Lleo, Alessio Aghemo. Clinical features and management issues of NAFLD-related HCC: what we know so far. Expert Review of Gastroenterology & Hepatology 2023; 17(1) doi: 10.1080/17474124.2023.2162503
173
Nikita Sehgal, Ruchi Jakhmola Mani, Nitu Dogra, Deepshikha Pande Katare. Biosensor Based Advanced Cancer Diagnostics. 2022;  doi: 10.1016/B978-0-12-823424-2.00009-0
174
Reshmi Mathew, Gregory Churchill, Bakht Cheema, Ketav Desai, Ahmad Alkhasawneh, Shiguang Liu, Anwer Siddiqi. Concomitant Gastric Malignancy and Hepatocellular Carcinoma. Cureus 2022;  doi: 10.7759/cureus.25607
175
Nisar Amin, Javaria Anwar, Abdullahi Sulaiman, Nadia Nikolaeva Naumova, Nadeem Anwar. Hepatocellular Carcinoma: A Comprehensive Review. Diseases 2025; 13(7) doi: 10.3390/diseases13070207
176
Eloy Ruiz, Pascal Pineau, Claudio Flores, Ramiro Fernández, Luis Cano, Juan Pablo Cerapio, Sandro Casavilca-Zambrano, Francisco Berrospi, Ivan Chávez, Benjamin Roche, Stéphane Bertani. A preoperative nomogram for predicting long-term survival after resection of large hepatocellular carcinoma (>10 cm). HPB 2022; 24(2) doi: 10.1016/j.hpb.2021.06.006
177
Ben L. Da, Aiwu Ruth He, Kirti Shetty, Kelly I. Suchman, Herbert Yu, Lawrence Lau, Linda L. Wong, Atoosa Rabiee, Richard L. Amdur, James M. Crawford, Sharon S. Fox, Gregory M. Grimaldi, Priya K. Shah, Jonathan Weinstein, David Bernstein, Sanjaya K. Satapathy, Nyasha Chambwe, Xiyan Xiang, Lopa Mishra. Pathogenesis to management of hepatocellular carcinoma. Genes & Cancer 2022; 13 doi: 10.18632/genesandcancer.226
178
Monika Pazgan-Simon, Anna Szymanek-Pasternal, Joanna Górka-Dynysiewicz, Anna Nowicka, Krzysztof Simon, Ewa Grzebyk, Michał Kukla. Serum chemerin level in patients with liver cirrhosis and primary and multifocal hepatocellular carcinoma with consideration of insulin level. Archives of Medical Science 2024;  doi: 10.5114/aoms/176674
179
Jonathan H. Joachim, Kosha J. Mehta. Hepcidin in hepatocellular carcinoma. British Journal of Cancer 2022; 127(2) doi: 10.1038/s41416-022-01753-2
180
Yucel Aydin, Ali R. Koksal, Paul Thevenot, Kelley Nunez, Mohamed Elgamal, Ulkuhan I. Koksal, Tyler Sandow, Martin Moehlen, Frederic Regenstein, Veysel Tahan, Ari Cohen. The number of hepatocellular carcinoma foci as predictor of poor response to tumor-directed therapies in patients awaiting liver transplantation: a prospective cohort study. European Journal of Gastroenterology & Hepatology 2023; 35(10) doi: 10.1097/MEG.0000000000002631
181
Qian Huang, Xin Xin, QinMei Sun, Ziming An, Xiaojun Gou, Qin Feng. Plant-derived bioactive compounds regulate the NLRP3 inflammasome to treat NAFLD. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.896899
182
Amer Latif, Riffat Saeed, Tariq Ali Banghash, Muhammad Khawar Shahzad, Hassam Ahmed, Muhammad Asif Naveed, Usama Amer. Validity of Prothrombin-induced Vitamin K antagonist versus Alpha-Fetoprotein (Tumor Markers) in Diagnosis of Hepatocellular Carcinoma, Using Computed Tomography scan as Gold Standard. Pakistan Journal of Health Sciences 2024;  doi: 10.54393/pjhs.v5i07.1804
183
Pranathi Pappu, Urvashi Vijay, Dhatri Madduru, Ngalah Bidii Stephen, Prashanth Suravajhala, Obul Reddy Bandapalli. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2. 2022;  doi: 10.1016/B978-0-323-98807-0.00005-3
184
Nazeer Ahmad Khan, Faisal Rashid, Muhammad Siraj Khan Jadoon, Saquib Jalil, Zulfiqar Ali Khan, Raha Orfali, Shagufta Perveen, Areej Al-Taweel, Jamshed Iqbal, Sohail Anjum Shahzad. Design, Synthesis, and Biological Evaluation of Novel Dihydropyridine and Pyridine Analogs as Potent Human Tissue Nonspecific Alkaline Phosphatase Inhibitors with Anticancer Activity: ROS and DNA Damage-Induced Apoptosis. Molecules 2022; 27(19) doi: 10.3390/molecules27196235
185
Abir Oufrid, Basma Aabboub, Diango Keita, Sara Nejjari, Samia El Hakym, Hafssa El Hilali, Chaymae Chbihi, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi, Nawfel Mellas. Metastatic Hepatocellular Carcinoma in a Non-Cirrhotic Liver without Viral Hepatitis: A Case Report and Literature Review. Journal of Cancer Therapy 2026; 17(01) doi: 10.4236/jct.2026.171007
186
Yee Hui Yeo, Hsiu J. Ho, Tsai-Wei Huang, Teng-Yu Lee, Ju Dong Yang, George Cholankeril, Chien-Jen Chen, Hawi-I. Yang, Chuen-Fei Chen, Hung-Chuen Chang, Chun-Ying Wu. Dynamic FIB-4 Score Changes and HCC Risk in Patients with MASLD and Elevated Liver Enzymes: A Nationwide Cohort Study. Liver Cancer 2026;  doi: 10.1159/000550360
187
Matthew August Odenwald, Sonali Paul. Viral hepatitis: Past, present, and future. World Journal of Gastroenterology 2022; 28(14): 1405-1429 doi: 10.3748/wjg.v28.i14.1405
188
Ifrah Fatima, Neehar D. Parikh, Alisa Likhitsup. Controversies of Direct-Acting Antivirals in Hepatocellular Carcinoma. Surgical Oncology Clinics of North America 2024; 33(1) doi: 10.1016/j.soc.2023.06.007
189
Mingyan Dong, Qi Cui, Yunong Li, Yujing Li, Qiuyu Chang, Ruixue Bai, Minjiie Wei, Lin zhao, Qili Chen. Ursolic acid suppresses fatty liver-associated hepatocellular carcinoma by regulating lipid metabolism. Food Bioscience 2024; 60 doi: 10.1016/j.fbio.2024.104460
190
Bibin Savio Antony, Subashini T S, Thangam C, Gowtham Kumar Subbaraj. Evaluation of MicroRNA gene polymorphisms (MicroRNA-149 (rs2292832), MicroRNA-146a (rs2910164), MicroRNA-196a2 (rs11614913)) and its association with liver cirrhosis (LC) and hepatocellular carcinoma (HCC). Egyptian Liver Journal 2025; 15(1) doi: 10.1186/s43066-025-00469-1
191
Chutian Wu, Yun Zhou, Min Wang, Guolin Dai, Xiongxiu Liu, Leizhen Lai, Shaohui Tang. Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver Disease. Frontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.772487
192
Benoit Schmauch, Sarah S. Elsoukkary, Amika Moro, Roma Raj, Chase J. Wehrle, Kazunari Sasaki, Julien Calderaro, Patrick Sin-Chan, Federico Aucejo, Daniel E. Roberts. Combining a deep learning model with clinical data better predicts hepatocellular carcinoma behavior following surgery. Journal of Pathology Informatics 2024; 15 doi: 10.1016/j.jpi.2023.100360
193
Zurabi Lominadze, Mohammed Rifat Shaik, Dabin Choi, Duha Zaffar, Lopa Mishra, Kirti Shetty. Hepatocellular Carcinoma Genetic Classification. The Cancer Journal 2023; 29(5) doi: 10.1097/PPO.0000000000000682
194
Sanaz Pashapour, Masoumeh Heshmati, Zahra Mousavi, Somayeh Esmaeili. The Cytotoxicity of the Chloroform and Petroleum Ether Fractional Extracts of Galium verum L. in HepG2 and HT29 Cell Lines. Journal of Kermanshah University of Medical Sciences 2020; 24(2) doi: 10.5812/jkums.101079
195
Neha Merchant, Sujatha Peela, Afroz Alam, Ganji Purnachandra Nagaraju. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022;  doi: 10.1016/B978-0-323-99283-1.00025-2
196
Sachin Sharma, Shaikh Maryam Ghufran, Basundhara Das, Bornika Roy, Sampa Ghose, Subhrajit Biswas. Survivin expression is essential for early activation of hepatic stellate cells and fibrosis progression in chronic liver injury. Life Sciences 2021; 287 doi: 10.1016/j.lfs.2021.120119
197
Matthias Van Haele, Janne Snoeck, Tania Roskams. Human Liver Regeneration: An Etiology Dependent Process. International Journal of Molecular Sciences 2019; 20(9) doi: 10.3390/ijms20092332
198
Pablo Lozano Lominchar, Maitane Igone Orue-Echebarria, Lorena Martín, Cristina Julia Lisbona, María Magdalena Salcedo, Luis Olmedilla, Hemant Sharma, Jose Manuel Asencio, José Ángel López-Baena. Hepatic flow is an intraoperative predictor of early allograft dysfunction in whole-graft deceased donor liver transplantation: An observational cohort study. World Journal of Hepatology 2019; 11(9): 689-700 doi: 10.4254/wjh.v11.i9.689
199
Shih-Wei Yang, Wei-Liang Chen, Wei-Te Wu, Chung-Ching Wang. Investigation on returning to work in liver cancer survivors in Taiwan: a 5-year follow-up study. BMC Public Health 2021; 21(1) doi: 10.1186/s12889-021-11872-9
200
Cemil Colak, Zeynep Kucukakcali, Sami Akbulut. Artificial intelligence-based prediction of molecular and genetic markers for hepatitis C–related hepatocellular carcinoma. Annals of Medicine & Surgery 2023; 85(10) doi: 10.1097/MS9.0000000000001210
201
Sonia Pascual, Cayetano Miralles, Juan M Bernabé, Javier Irurzun, Mariana Planells. Surveillance and diagnosis of hepatocellular carcinoma: A systematic review. World Journal of Clinical Cases 2019; 7(16): 2269-2286 doi: 10.12998/wjcc.v7.i16.2269
202
Magdalena Stepien, Pekka Keski‐Rahkonen, Agneta Kiss, Nivonirina Robinot, Talita Duarte‐Salles, Neil Murphy, Gabriel Perlemuter, Vivian Viallon, Anne Tjønneland, Agnetha Linn Rostgaard‐Hansen, Christina C. Dahm, Kim Overvad, Marie‐Christine Boutron‐Ruault, Francesca Romana Mancini, Yahya Mahamat‐Saleh, Krasimira Aleksandrova, Rudolf Kaaks, Tilman Kühn, Antonia Trichopoulou, Anna Karakatsani, Salvatore Panico, Rosario Tumino, Domenico Palli, Giovanna Tagliabue, Alessio Naccarati, Roel C.H. Vermeulen, Hendrik Bastiaan Bueno‐de‐Mesquita, Elisabete Weiderpass, Guri Skeie, Jose Ramón Quirós, Eva Ardanaz, Olatz Mokoroa, Núria Sala, Maria‐Jose Sánchez, José María Huerta, Anna Winkvist, Sophia Harlid, Bodil Ohlsson, Klas Sjöberg, Julie A. Schmidt, Nick Wareham, Kay‐Tee Khaw, Pietro Ferrari, Joseph A. Rothwell, Marc Gunter, Elio Riboli, Augustin Scalbert, Mazda Jenab. Metabolic perturbations prior to hepatocellular carcinoma diagnosis: Findings from a prospective observational cohort study. International Journal of Cancer 2021; 148(3) doi: 10.1002/ijc.33236
203
Lateef A. Sulaimon, Rahmat A. Adisa, Titilola A. Samuel, Fatimah B. Abdulkareem, Akinrinade G. Ayankojo. Mitoquinol mesylate alleviates oxidative damage in cirrhotic and advanced hepatocellular carcinogenic rats through mitochondrial protection and antioxidative effects. Advances in Redox Research 2021; 3 doi: 10.1016/j.arres.2021.100014
204
Peter D. Block, Joseph K. Lim. Unmet needs in the clinical management of chronic hepatitis B infection. Journal of the Formosan Medical Association 2025; 124(6) doi: 10.1016/j.jfma.2024.08.020
205
Haeryoung Kim, Wei-Qiang Leow, Regina Lo, Paulo Giovanni L. Mendoza, Anthony Wing-Hung Chan. Atlas of Hepatocellular Carcinoma Pathology. 2022;  doi: 10.1007/978-981-16-8500-2_1
206
. 2019;  doi: 10.70675/6b177437zf347z443bz8bb8z528243af0fa5
207
Luis Cesar Bredt, Ingryd Betina Garcia Felisberto, Doroty Eva Garcia Felisberto. Is there a role for liver transplantation in the treatment of hepatocellular carcinoma in non-cirrhotic liver?. World Journal of Meta-Analysis 2022; 10(2): 46-51 doi: 10.13105/wjma.v10.i2.46
208
Said A. Al-Busafi, Khalid AlNaamani. Liver Cancer in the Middle East. 2021;  doi: 10.1007/978-3-030-78737-0_17
209
Catherine Leyh, Jason D. Coombes, Hartmut H. Schmidt, Ali Canbay, Paul P. Manka, Jan Best. MASLD-Related HCC—Update on Pathogenesis and Current Treatment Options. Journal of Personalized Medicine 2024; 14(4) doi: 10.3390/jpm14040370
210
Gehad Ahmad Saleh, Ahmed Abdel Khalek Abdel Razek, Lamiaa Galal El-Serougy, Walaa Shabana, Rihame Abd El-Wahab. The value of the apparent diffusion coefficient value in the Liver Imaging Reporting and Data System version 2018. Polish Journal of Radiology 2022; 87 doi: 10.5114/pjr.2022.113193
211
Manfred Schmidt, Graham R. Foster, Michiel Coppens, Hauke Thomsen, Ricardo Dolmetsch, Liesbeth Heijink, Paul E. Monahan, Steven W. Pipe. Molecular evaluation and vector integration analysis of HCC complicating AAV gene therapy for hemophilia B. Blood Advances 2023; 7(17) doi: 10.1182/bloodadvances.2023009876
212
Jinqi Tu, Bo Wang, Xiaoming Wang, Kugeng Huo, Wanting Hu, Rongli Zhang, Jinyao Li, Shijie Zhu, Qionglin Liang, Shuxin Han. Current status and new directions for hepatocellular carcinoma diagnosis. Liver Research 2024; 8(4) doi: 10.1016/j.livres.2024.12.001
213
Marco Dioguardi Burgio, Roberto Cannella, Federica Vernuccio, Maxime Ronot, Valérie Vilgrain. HCC in MASLD: radiological appearance, diagnosis and treatment. Hepatoma Research 2025;  doi: 10.20517/2394-5079.2024.117
214
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]. 2019;  doi: 10.5772/intechopen.86638
215
Na Young Lee, Ki Tae Suk. The Role of the Gut Microbiome in Liver Cirrhosis Treatment. International Journal of Molecular Sciences 2020; 22(1) doi: 10.3390/ijms22010199
216
Abhilash Perisetti, Hemant Goyal, Rachana Yendala, Ragesh B Thandassery, Emmanouil Giorgakis. Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements. World Journal of Gastroenterology 2021; 27(24): 3466-3482 doi: 10.3748/wjg.v27.i24.3466
217
Shintaro Ichikawa, Hiroyuki Morisaka, Yoshie Omiya, Hiroshi Onishi. Distinction Between Hepatocellular Carcinoma and Hypervascular Liver Metastases in Non-cirrhotic Patients Using Gadoxetate Disodium-Enhanced Magnetic Resonance Imaging. Canadian Association of Radiologists Journal 2022; 73(4) doi: 10.1177/08465371221085516
218
Sonia Triggiani, Maria T. Contaldo, Giulia Mastellone, Maurizio Cè, Anna M. Ierardi, Gianpaolo Carrafiello, Michaela Cellina. The Role of Artificial Intelligence and Texture Analysis in Interventional Radiological Treatments of Liver Masses: A Narrative Review . Critical Reviews™ in Oncogenesis 2024; 29(2) doi: 10.1615/CritRevOncog.2023049855
219
Joo Hyun Oh, Myung Ji Goh, Yewan Park, Jihye Kim, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Yong-Han Paik. Different Performance of Liver Stiffness Measurement According to Etiology and Outcome for the Prediction of Liver-Related Events. Digestive Diseases and Sciences 2021; 66(8) doi: 10.1007/s10620-020-06591-x
220
Naima Zayed Mohamed, Hanan Farouk Aly, Hatem Abdel moneim El-Mezayen, Hadeer E. El-Salamony. Effect of co-administration of Bee honey and some chemotherapeutic drugs on dissemination of hepatocellular carcinoma in rats. Toxicology Reports 2019; 6 doi: 10.1016/j.toxrep.2019.08.007
221
Carolina Palma, Francisco Vara-Luíz, Ivo Mendes, Bruno Correia, Filipe Nogueira, Cristina Fonseca. Paraneoplastic Pemphigus and Liver Biopsy Needle Track Dissemination in Hepatocellular Carcinoma: A Case Report. GE - Portuguese Journal of Gastroenterology 2026;  doi: 10.1159/000550555
222
Susanne Feder, Arne Kandulski, Doris Schacherer, Thomas S. Weiss, Christa Buechler. Serum Chemerin Does Not Differentiate Colorectal Liver Metastases from Hepatocellular Carcinoma. International Journal of Molecular Sciences 2019; 20(16) doi: 10.3390/ijms20163919
223
Robert M. Shavelle, Ji Hun Kwak, Rachel Saur, Jordan C. Brooks, Philip Rosenthal. Life Expectancy after Liver Transplantation for Non-Cirrhotic Hepatocellular Carcinoma. Progress in Transplantation 2021; 31(2) doi: 10.1177/15269248211002793
224
Siyu Fu, Teoman Deger, Ruben G. Boers, Joachim B. Boers, Michael Doukas, Joost Gribnau, Saskia M. Wilting, José D. Debes, Andre Boonstra. Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma. Cancers 2023; 15(19) doi: 10.3390/cancers15194784
225
Yaojie Fu, Luca Maccioni, Xin Wei Wang, Tim F. Greten, Bin Gao. Alcohol-associated liver cancer. Hepatology 2024; 80(6) doi: 10.1097/HEP.0000000000000890
226
Gianni TESTINO, Sharmila FAGOONEE, Fabio CAPUTO, Rinaldo PELLICANO. The early identification of alcohol use disorders and liver injury: proposal for a diagnostic algorithm. Panminerva Medica 2021; 63(3) doi: 10.23736/S0031-0808.21.04272-5
227
Cristiane Valle Tovo, Angelo Zambam de Mattos, Gabriela Perdomo Coral, Giovana D P Sartori, Livia Villela Nogueira, Gustavo Tovo Both, Cristiane A Villela-Nogueira, Angelo A de Mattos. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis. World Journal of Gastroenterology 2023; 29(2): 343-356 doi: 10.3748/wjg.v29.i2.343
228
Juliet Emamaullee, Ali N. Zaidi, Thomas Schiano, Jeffrey Kahn, Pamela L. Valentino, Ryan E. Hofer, Timucin Taner, Joyce W. Wald, Kim M. Olthoff, John Bucuvalas, Ryan Fischer. Fontan-Associated Liver Disease. Circulation 2020; 142(6) doi: 10.1161/CIRCULATIONAHA.120.045597
229
Davide Giuseppe Ribaldone, Gian Paolo Caviglia, Silvia Gaia, Emanuela Rolle, Alessandra Risso, Daniela Campion, Paola Rita Brunocilla, Giorgio Maria Saracco, Patrizia Carucci. Effect of COVID-19 Pandemic on Hepatocellular Carcinoma Diagnosis: Results from a Tertiary Care Center in North-West Italy. Current Oncology 2022; 29(3) doi: 10.3390/curroncol29030119
230
A. Riojas-Garza, M. González-Urquijo, C.E. Escareño-Pérez, I. Vázquez-Ávila, F.J. Bosques-Padilla. Caudate lobe hepatocellular carcinoma in a noncirrhotic patient with a history of chronic phenytoin intake and celiac disease treated with isolated caudate lobe resection. A case report. Revista de Gastroenterología de México (English Edition) 2022; 87(2) doi: 10.1016/j.rgmxen.2022.05.011
231
Jay H. Lefkowitch. Scheuer's Liver Biopsy Interpretation. 2021;  doi: 10.1016/B978-0-7020-7584-1.00006-1
232
Abid M. Sadiq, Tendai J. Mashonganyika, Lilian G. Mmbaga, Adnan M. Sadiq, Gilbert Z. Nkya. Hepatocellular carcinoma in a non‐cirrhotic liver with a tumor thrombus. Clinical Case Reports 2021; 9(9) doi: 10.1002/ccr3.4800
233
Sancharan Acharya, Subramaniyam Nithyananthan, Chinnasamy Thirunavukkarasu. Selenium Nanoparticles Show Anticancer Activity Through Regulation of HIF-1α and HIF-2α Under Hypoxic Condition in Liver Cancer Cells. DNA and Cell Biology 2023; 42(7) doi: 10.1089/dna.2023.0099
234
Akiko Eguchi, Motoh Iwasa, Minori Yamada, Yasuyuki Tamai, Ryuta Shigefuku, Hiroshi Hasegawa, Yoshifumi Hirokawa, Akinobu Hayashi, Koji Okuno, Yuki Matsushita, Takuma Nakatsuka, Kenichiro Enooku, Koji Sakaguchi, Yoshinao Kobayashi, Tetsuji Yamaguchi, Masatoshi Watanabe, Yoshiyuki Takei, Hayato Nakagawa. A new detection system for serum fragmented cytokeratin 18 as a biomarker reflecting histologic activities of human nonalcoholic steatohepatitis. Hepatology Communications 2022; 6(8) doi: 10.1002/hep4.1971
235
Maria Rosaria Paravati, Giuseppe Guido Maria Scarlata, Maja Milanović, Nataša Milić, Ludovico Abenavoli. The anticancer activity of quercetin, luteolin, myricetin, and kaempferol in the development of hepatocellular carcinoma: a narrative review. Hepatoma Research 2024;  doi: 10.20517/2394-5079.2024.86
236
Mariana N. Batista, Juliano Bordignon, Ana L. P. Mosimann, Tesia Bobrowski, Hsuan-An Chen, Gabriel Tobin-Xet, Erika A. Barrall, Nataliya Prokhnevska, Abishek B. Vaidya, Tyler Lewy, Kenneth H. Dinnon, Leon L. Seifert, Briana Zeck, Corrine Quirk, Yu-Jui Ho, Aveline Filliol, Raphael Wolfisberg, Caroline Jiang, Bruno Cogliati, Luis Chiriboga, Neil Theise, Margaret R. MacDonald, Alice O. Kamphorst, Troels K.H. Scheel, Timothy P. Sheahan, Eva Billerbeck, Scott W. Lowe, Brad R. Rosenberg, Charles M. Rice. An immunocompetent murine model of virus-elicited liver fibrosis and hepatocellular carcinoma. Journal of Hepatology 2026; 84(6) doi: 10.1016/j.jhep.2026.02.020
237
Adrià Ramírez Mena, Mbaye Thiam, Daye Ka, Ibrahima Niang, Judicaël Tine, Louise Fortes, Kiné Ndiaye, Ousseynou Ndiaye, Maguette Fall, Assietou Gaye, Ndeye Fatou Ngom, Fatou Fall, Annalisa Berzigotti, Gregory Dale Kirk, Antoine Jaquet, Moussa Seydi, Gilles Wandeler. Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort study. The Lancet Gastroenterology & Hepatology 2024; 9(6) doi: 10.1016/S2468-1253(24)00040-2
238
Kazuma Sekiba, Motoyuki Otsuka, Kazuhiko Koike. Potential of HBx Gene for Hepatocarcinogenesis in Noncirrhotic Liver. Seminars in Liver Disease 2021; 41(02) doi: 10.1055/s-0041-1723033
239
Wei Cao, Olga Sergeeva, William Julian, Adam Kresak, Destiny Lusinger, Joseph Schneider, Marc S. Berridge, Sandra Sexton, Patrick Wojtylak, Qiubai Li, Wendy Liu, Ernest Ricky Chan, Yogen Saunthararajah, Zhenghong Lee. PET imaging of hepatocellular carcinoma with [124I]IV-14. EJNMMI Research 2025; 15(1) doi: 10.1186/s13550-025-01227-5
240
Mizuki Endo, Koichi Honda, Tomoko Tokumaru, Tomoko Saito, Takuro Uchida, Masao Iwao, Mie Arakawa, Masataka Seike, Masaaki Kodama, Takashi Masuda, Yuichi Endo, Masafumi Inomata, Kazunari Murakami, Kazuhiro Mizukami. Hepatocellular carcinoma in F0 livers: Clinical and prognostic insights. World Journal of Gastrointestinal Oncology 2026; 18(4): 115576 doi: 10.4251/wjgo.v18.i4.115576
241
Zhenghong Lee, Zheng-Rong Lu, Sandra Sexton, Wei Xin. PET imaging with FAPI-ligands for non-cirrhotic hepatocellular carcinoma. European Journal of Nuclear Medicine and Molecular Imaging 2023; 50(11) doi: 10.1007/s00259-023-06324-y
242
Yu-Jen Chen, Chien-Wei Su, Cheng-Yi Wei, Gar-Yang Chau, Ping-Hsien Chen, Yee Chao, Yi-Hsiang Huang, Jaw-Ching Wu, Tsung-Chieh Yang, Pei-Chang Lee, Ming-Chih Hou. Comparison of prognoses between cirrhotic and noncirrhotic patients with hepatocellular carcinoma and esophageal varices undergoing surgical resection. Journal of the Chinese Medical Association 2022; 85(6) doi: 10.1097/JCMA.0000000000000739
243
Naseem Ravanbakhsh, Andres Rivera Campana, Catherine Chapin, Ravi Jhaveri. Hepatitis B Virus Treatment in Children: Common Challenges and Management Options in a Case-Based Format. Journal of the Pediatric Infectious Diseases Society 2024; 13(Supplement_5) doi: 10.1093/jpids/piae084
244
Priya Singh, Parul Gupta, Arka De, Ajay Duseja. Molecular Characterization of Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis: Implications for Immunotherapy. Journal of Clinical and Experimental Hepatology 2023; 13(6) doi: 10.1016/j.jceh.2023.03.001
245
Ruzan Udumyan, Scott Montgomery, Ann-Sofi Duberg, Fang Fang, Unnur Valdimarsdottir, Anders Ekbom, Karin E. Smedby, Katja Fall. Beta-adrenergic receptor blockers and liver cancer mortality in a national cohort of hepatocellular carcinoma patients. Scandinavian Journal of Gastroenterology 2020; 55(5) doi: 10.1080/00365521.2020.1762919
246
Naoki Kirihata, Yoshiko Nakano, Koki Moriyoshi, Shin'ichi Miyamoto. Ruptured hepatocellular carcinoma developed in a normal liver in a young patient with a body mass index of 33 kg/m2 . BMJ Case Reports 2024; 17(12) doi: 10.1136/bcr-2024-262841
247
Norberto C Chavez-Tapia, Sofía Murúa-Beltrán Gall, Ana Luisa Ordoñez-Vázquez, Natalia Nuño-Lambarri, Paulina Vidal-Cevallos, Misael Uribe. Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2022;  doi: 10.2147/JHC.S283840
248
Souvik Sarkar, Aniket Alurwar, Carole Ly, Cindy Piao, Rajiv Donde, Christopher J. Wang, Frederick J. Meyers. A Machine Learning Model to Predict Risk for Hepatocellular Carcinoma in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease. Gastro Hep Advances 2024; 3(4) doi: 10.1016/j.gastha.2024.01.007
249
Jong Man Kim, Jinsoo Rhu, Sang Yun Ha, Gyu-Seong Choi, Choon Hyuck David Kwon, Jae-Won Joh. Hepatectomy outcomes in patients with hepatitis C virus-related hepatocellular carcinoma with or without cirrhosis. Annals of Surgical Treatment and Research 2022; 102(1) doi: 10.4174/astr.2022.102.1.1
250
Sangmi Jang, Young-Joo Jin, Jin-Woo Lee, Dam Kwon, Jung Hwan Yu. Risk factors associated with late hepatocellular carcinoma detection in patients undergoing regular surveillance. Medicine 2023; 102(32) doi: 10.1097/MD.0000000000034637
251
Martijn P.A. Starmans, Razvan L. Miclea, Valerie Vilgrain, Maxime Ronot, Yvonne Purcell, Jef Verbeek, Wiro J. Niessen, Jan N.M. Ijzermans, Rob A. de Man, Michael Doukas, Stefan Klein, Maarten G. Thomeer. Automated Assessment of T2-Weighted MRI to Differentiate Malignant and Benign Primary Solid Liver Lesions in Noncirrhotic Livers Using Radiomics. Academic Radiology 2024; 31(3) doi: 10.1016/j.acra.2023.07.024
252
Brian McMahon, Chari Cohen, Robert S Brown Jr, Hashem El-Serag, George N Ioannou, Anna S Lok, Lewis R Roberts, Amit G Singal, Timothy Block. Opportunities to address gaps in early detection and improve outcomes of liver cancer. JNCI Cancer Spectrum 2023; 7(3) doi: 10.1093/jncics/pkad034
253
Thomas Tu, Thomas J. McQuaid, Ira M. Jacobson. HBV‐Induced Carcinogenesis: Mechanisms, Correlation With Viral Suppression, and Implications for Treatment. Liver International 2025; 45(1) doi: 10.1111/liv.16202
254
José Leão Mendes, Ana Sofia Spencer, João Cabral Pimentel, Mariana Sardinha, João Boavida Ferreira, Ricardo da Luz. Five-Year Sustained Response to Nivolumab in Hepatocellular Carcinoma following Serious Immune-Related Hepatitis. GE - Portuguese Journal of Gastroenterology 2024; 32(5) doi: 10.1159/000543288
255
Anisha Jain, Benjamin Mazer, Yanhong Deng, Maria Ciarleglio, Dhanpat Jain, Tamar Taddei, Xuchen Zhang. Hepatocellular Carcinoma. American Journal of Clinical Pathology 2022; 157(2) doi: 10.1093/ajcp/aqab125
256
. 2022;  doi: 10.70675/38f85785z82fez460azb8e2z9f96886aaa72
257
Eleonora Salles-Silva, Paula Lemos de Castro, Luiza Carvalho Ambrozino, Antonio Luis-Eiras de Araújo, Daniel Lahan-Martins, Maria Fernanda Arruda Almeida, Fabiano Rubião Lucchesi, Eduardo Oliveira Pacheco, Ulysses S. Torres, Giuseppe D’Ippolito, Daniella Braz Parente. Rare Malignant Liver Tumors: Current Insights and Imaging Challenges. Seminars in Ultrasound, CT and MRI 2025; 46(3) doi: 10.1053/j.sult.2025.04.007
258
L.E. Cisneros-Garza, M.S. González-Huezo, C. Moctezuma-Velázquez, L. Ladrón de Guevara-Cetina, M. Vilatobá, I. García-Juárez, R. Alvarado-Reyes, G.A. Álvarez-Treviño, S. Allende-Pérez, L. Bornstein-Quevedo, G. Calderillo-Ruiz, M.A. Carrillo-Martínez, M. Castillo-Barradas, E. Cerda-Reyes, J.A. Félix-Leyva, J.A. Gabutti-Thomas, J. Guerrero-Ixtlahuac, F. Higuera-de-la-Tijera, D. Huitzil-Meléndez, E. Kimura-Hayama, P.A. López-Hernández, R. Malé-Velázquez, N. Méndez-Sánchez, M.A. Morales-Ruiz, E. Ruíz-García, J.F. Sánchez-Ávila, L. Torrecillas-Torres. II Consenso Mexicano de Carcinoma Hepatocelular. Parte I: Epidemiología y diagnóstico. Revista de Gastroenterología de México 2022; 87(2) doi: 10.1016/j.rgmx.2021.10.002
259
Jasper Okoro Godwin Elechi, Carolina Ramos de Mendonça, Vitor Carlos de Araújo Bandeira, Maria Surama Pereira Da Silva, Ana Paula Rocha de Melo, Rubem Carlos Araujo Guedes, Sandro Massao Hirabara, Erika Cione, Diogo Antonio Alves de Vasconcelos. Exploring recent insights on intermittent fasting in regulating glucocorticoid levels and diet-induced metabolic disorders with focus on MAFLD and hepatic outcomes. Molecular and Cellular Endocrinology 2026; 614 doi: 10.1016/j.mce.2026.112736
260
Alisa A. Petkevich, Aleksandr A. Abramov, Vadim I. Pospelov, Natalya A. Malinina, Elena I. Kuhareva, Natalya V. Mazurchik, Olga I. Tarasova. Exosomal and non-exosomal miRNA expression levels in patients with HCV-related cirrhosis and liver cancer. Oncotarget 2021; 12(17) doi: 10.18632/oncotarget.28036
261
Saleh A. Alqahtani, Wah-Kheong Chan, Ming-Lung Yu. Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma. Clinics in Liver Disease 2023; 27(2) doi: 10.1016/j.cld.2023.01.019
262
Thomas Grewal, Christa Buechler. Anti-Angiogenic Features of Endostatin in Obesity, Liver Fibrosis, and Hepatocellular Carcinoma. Biomedicines 2026; 14(3) doi: 10.3390/biomedicines14030734
263
Sofi Dhanaraj, Tahir Shah, Joanne O'Rourke, Shishir Shetty. Hepatocellular carcinoma: update on treatment guidelines. Gastrointestinal Nursing 2020; 18(Sup10) doi: 10.12968/gasn.2020.18.Sup10.S18
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.